SEK 99.55
Key Takeaways
Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equipment; veterinary equipment; surgical...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of ASKER.ST is 103 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio
